glp-1 information Understanding semaglutide (GLP-1 RA): Are they the right choice for weight loss? GLP-1 medications like Ozempic are
Description
Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity
Your Daily Metabolic Ally
These drugs significantly reduced rates of #coloncancer (16% fewer cases) and #rectalcancer (28% fewer cases), among others like post-menopausal #breastcancer, #endometrialcancer, and #pancreaticcancer
Methods A systematic review was conducted following PRISMA 2020 guidelines (PROSPERO: CRD420261305875)
Explore tirzepatides safety for weight loss and diabetes, how it compares to Ozempic, and the role of Healthons compounded tirzepatide.
Empower is a major 503A/503B compounder offering semaglutide and tirzepatide nationwide, but its record includes repeated FDA scrutiny.
